| Overview |
| bs-9861R-PE-Cy5.5 |
| Titin Polyclonal Antibody, PE-Cy5.5 Conjugated |
| FCM |
| Human, Mouse, Rat, Others |
| Specifications |
| PE-Cy5.5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Titin (Ig-like 15 domain) |
| 2601-2800/34350 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 7273 |
| Q8WZ42 |
| TMD; CMH9; CMD1G; CMPD4; EOMFC; HMERF; MYLK5; LGMD2J; Titin; Connectin; Rhabdomyosarcoma antigen MU-RMS-40.14; TTN |
| Key component in the assembly and functioning of vertebrate striated muscles. By providing connections at the level of individual microfilaments, it contributes to the fine balance of forces between the two halves of the sarcomere. The size and extensibility of the cross-links are the main determinants of sarcomere extensibility properties of muscle. In non-muscle cells, seems to play a role in chromosome condensation and chromosome segregation during mitosis. Might link the lamina network to chromatin or nuclear actin, or both during interphase. |
| Application Dilution |
| FCM |
1:20-100 |
Powered by Bioz